Annual CFO
-$29.06 M
-$698.90 K-2.46%
30 September 2023
Summary:
Citius Pharmaceuticals annual cash flow from operations is currently -$29.06 million, with the most recent change of -$698.90 thousand (-2.46%) on 30 September 2023. During the last 3 years, it has fallen by -$4.81 million (-19.83%). CTXR annual CFO is now -143053.69% below its all-time high of -$20.30 thousand, reached on 30 September 2012.CTXR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$8.37 M
-$581.40 K-7.47%
30 June 2024
Summary:
Citius Pharmaceuticals quarterly cash flow from operations is currently -$8.37 million, with the most recent change of -$581.40 thousand (-7.47%) on 30 June 2024. Over the past year, it has dropped by -$1.57 million (-23.05%). CTXR quarterly CFO is now -4183600.00% below its all-time high of -$200.00, reached on 31 December 2012.CTXR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$29.09 M
+$1.22 M+4.01%
30 June 2024
Summary:
Citius Pharmaceuticals TTM cash flow from operations is currently -$29.09 million, with the most recent change of +$1.22 million (+4.01%) on 30 June 2024. Over the past year, it has dropped by -$28.70 thousand (-0.10%). CTXR TTM CFO is now -969530.00% below its all-time high of -$3000.00, reached on 31 December 2010.CTXR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTXR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -23.1% | -0.1% |
| 3 y3 years | -19.8% | -49.7% | -19.9% |
| 5 y5 years | -133.6% | -187.8% | -133.9% |
CTXR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.8% | at low | -79.9% | +13.4% | -50.4% | +4.2% |
| 5 y | 5 years | -133.6% | at low | -187.8% | +13.4% | -133.9% | +4.2% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +13.4% | <-9999.0% | +4.2% |
Citius Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$8.37 M(+7.5%) | -$29.09 M(-4.0%) |
| Mar 2024 | - | -$7.79 M(+26.9%) | -$30.30 M(-0.2%) |
| Dec 2023 | - | -$6.14 M(-9.8%) | -$30.37 M(+4.5%) |
| Sept 2023 | -$29.06 M(+2.5%) | -$6.80 M(-29.0%) | -$29.06 M(+1.6%) |
| June 2023 | - | -$9.58 M(+22.0%) | -$28.59 M(+7.0%) |
| Mar 2023 | - | -$7.85 M(+62.8%) | -$26.72 M(-6.4%) |
| Dec 2022 | - | -$4.82 M(-23.8%) | -$28.53 M(+0.6%) |
| Sept 2022 | - | -$6.33 M(-17.9%) | -$28.36 M(+2.7%) |
| Sept 2022 | -$28.36 M(+17.0%) | - | - |
| June 2022 | - | -$7.71 M(-20.2%) | -$27.62 M(+11.7%) |
| Mar 2022 | - | -$9.67 M(+107.8%) | -$24.73 M(+27.9%) |
| Dec 2021 | - | -$4.65 M(-16.8%) | -$19.34 M(-20.3%) |
| Sept 2021 | -$24.25 M(+43.2%) | -$5.59 M(+15.9%) | -$24.25 M(+10.1%) |
| June 2021 | - | -$4.82 M(+12.9%) | -$22.02 M(+3.9%) |
| Mar 2021 | - | -$4.27 M(-55.3%) | -$21.18 M(-0.9%) |
| Dec 2020 | - | -$9.56 M(+184.8%) | -$21.38 M(+26.3%) |
| Sept 2020 | -$16.93 M(+36.1%) | -$3.36 M(-15.9%) | -$16.93 M(+2.7%) |
| June 2020 | - | -$3.99 M(-10.7%) | -$16.48 M(+2.9%) |
| Mar 2020 | - | -$4.47 M(-12.6%) | -$16.01 M(+4.0%) |
| Dec 2019 | - | -$5.11 M(+75.9%) | -$15.39 M(+23.8%) |
| Sept 2019 | -$12.44 M(+9.9%) | -$2.91 M(-17.5%) | -$12.44 M(+3.3%) |
| June 2019 | - | -$3.52 M(-8.5%) | -$12.04 M(+11.9%) |
| Mar 2019 | - | -$3.85 M(+78.3%) | -$10.76 M(-2.5%) |
| Dec 2018 | - | -$2.16 M(-13.8%) | -$11.04 M(-2.5%) |
| Sept 2018 | -$11.32 M | -$2.50 M(+11.5%) | -$11.32 M(-7.6%) |
| June 2018 | - | -$2.25 M(-45.6%) | -$12.24 M(-1.3%) |
| Mar 2018 | - | -$4.13 M(+69.0%) | -$12.40 M(+36.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | -$2.44 M(-28.8%) | -$9.10 M(+14.1%) |
| Sept 2017 | -$7.97 M(+35.1%) | -$3.43 M(+42.7%) | -$7.97 M(+26.4%) |
| June 2017 | - | -$2.40 M(+191.3%) | -$6.31 M(-2.5%) |
| Mar 2017 | - | -$824.60 K(-37.3%) | -$6.47 M(-0.8%) |
| Dec 2016 | - | -$1.31 M(-25.6%) | -$6.52 M(+10.5%) |
| Sept 2016 | -$5.90 M(+147.4%) | -$1.77 M(-31.0%) | -$5.90 M(+21.9%) |
| June 2016 | - | -$2.56 M(+193.0%) | -$4.84 M(+66.6%) |
| Mar 2016 | - | -$874.50 K(+25.4%) | -$2.91 M(+23.8%) |
| Dec 2015 | - | -$697.10 K(-1.2%) | -$2.35 M(-1.6%) |
| Sept 2015 | -$2.39 M(>+9900.0%) | -$705.30 K(+12.2%) | -$2.39 M(+42.0%) |
| June 2015 | - | -$628.40 K(+98.3%) | -$1.68 M(+52.7%) |
| Mar 2015 | - | -$316.90 K(-56.9%) | -$1.10 M(+34.9%) |
| Dec 2014 | - | -$734.80 K(+1415.1%) | -$815.80 K(+33.7%) |
| June 2014 | - | -$48.50 K(+49.2%) | -$610.30 K(+8.0%) |
| Mar 2014 | - | -$32.50 K(-93.8%) | -$565.00 K(+4.2%) |
| Dec 2013 | - | -$521.90 K(+6952.7%) | -$542.20 K(+2544.9%) |
| Sept 2013 | -$20.60 K(+1.5%) | -$7400.00(+131.3%) | -$20.50 K(+10.8%) |
| June 2013 | - | -$3200.00(-67.0%) | -$18.50 K(-13.1%) |
| Mar 2013 | - | -$9700.00(+4750.0%) | -$21.30 K(+16.4%) |
| Dec 2012 | - | -$200.00(-96.3%) | -$18.30 K(-9.9%) |
| Sept 2012 | -$20.30 K(-2.4%) | -$5400.00(-10.0%) | -$20.30 K(+2.5%) |
| June 2012 | - | -$6000.00(-10.4%) | -$19.80 K(+4.8%) |
| Mar 2012 | - | -$6700.00(+204.5%) | -$18.90 K(-5.0%) |
| Dec 2011 | - | -$2200.00(-55.1%) | -$19.90 K(-3.9%) |
| Sept 2011 | -$20.80 K | -$4900.00(-3.9%) | -$20.70 K(+31.0%) |
| June 2011 | - | -$5100.00(-33.8%) | -$15.80 K(+47.7%) |
| Mar 2011 | - | -$7700.00(+156.7%) | -$10.70 K(+256.7%) |
| Dec 2010 | - | -$3000.00 | -$3000.00 |
FAQ
- What is Citius Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly CFO year-on-year change?
- What is Citius Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM CFO year-on-year change?
What is Citius Pharmaceuticals annual cash flow from operations?
The current annual CFO of CTXR is -$29.06 M
What is the all time high annual CFO for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual cash flow from operations is -$20.30 K
What is Citius Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CTXR is -$8.37 M
What is the all time high quarterly CFO for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly cash flow from operations is -$200.00
What is Citius Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CTXR quarterly cash flow from operations has changed by -$1.57 M (-23.05%)
What is Citius Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CTXR is -$29.09 M
What is the all time high TTM CFO for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM cash flow from operations is -$3000.00
What is Citius Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CTXR TTM cash flow from operations has changed by -$28.70 K (-0.10%)